Third Harmonic Bio Announces Pricing of Upsized Initial
CAMBRIDGE, Mass., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company developing a...
Source: globenewswire.com
📰 Third Harmonic News
Page 2 - Third Harmonic News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Third Harmonic. Real-time updates on events, politics, business and more.
Third Harmonic pushes IPO window open with inflammation drug from Novartis
Third Harmonic Bio, which emerged from stealth early this year with a lead drug from Novartis and a $105 million round of funding, has not yet set any financial terms for its planned IPO. But the biotech plans to use the IPO cash for clinical early and mid-stage clinical tests of its small molecule in multiple inflammatory indications.
United Kingdom Astellas Pharma Natalie Holles Celldex Therapeutics Novartis Institutes For Biomedical Research Atlas Venture
Source: medcitynews.com
Third Harmonic Bio Appoints Thomas M. Soloway to its Board
CAMBRIDGE, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company developing a potent, highly...
Source: globenewswire.com
Third Harmonic Bio Appoints Thomas M. Soloway to its Board of Directors
CAMBRIDGE, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company developing a potent, highly selective, oral KIT inhibitor for the treatment of severe allergy
Source: kulr8.com
Investegate |RTW Venture Fund Ltd Announcements | RTW Venture Fund Ltd: New Investment in Third Harmonic Bio
Investegate announcements from RTW Venture Fund Ltd, New Investment in Third Harmonic Bio
Source: investegate.co.uk